Dimeric 4-Aryl-1,4-Dihydropyridines: Development of a Third Class of Nonpeptidic HIV-1 Protease Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 2, Iss. 3, 2002-06 ,pp. : 235-245

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-activity relationships of first bishydroxymethyl-substituted cage dimeric 4-aryl-1,4-dihydropyridines as HIV-1 protease inhibitors

By Hilgeroth A.   Lilie H.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 5, 2003-05 ,pp. : 495-499

Elsevier

Access to resources Recommend Favorite

Synthesis and biological evaluation of first N-alkyl syn dimeric 4-aryl-1,4-dihydropyridines as competitive HIV-1 protease inhibitors

By Hilgeroth A.   Billich A.   Lilie H.  

European Journal of Medicinal Chemistry, Vol. 36, Iss. 4, 2001-04 ,pp. : 367-374

Elsevier

Access to resources Recommend Favorite

Optimization of Important Early ADME(T) Parameters of NADPH Oxidase-4 Inhibitor Molecules

By  

Medicinal Chemistry, Vol. 8, Iss. 2, 2012-03 ,pp. : 174-181

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Lipase-Catalyzed Hydrolytic Approaches to Pharmacologically Important &bgr;-and &ggr;-Amino Acids

By  

Current Medicinal Chemistry, Vol. 19, Iss. 36, 2012-12 ,pp. : 6178-6187

Bentham Science Publishers

Access to resources Recommend Favorite